Streetbeat News

Corporate Responsibility

AEON

AEON Biopharma, Inc. (NYSE:AEON) announced a strategic reprioritization and cost reduction plan, including a 55% workforce reduction, to extend its cash runway into Q4 2024. The company is evaluating financing options for its late-stage clinical pipeline for ABP-450.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:17 pm

BNTX

BioNTech and CEPI are expanding their partnership to enhance Africa's mRNA vaccine ecosystem. CEPI will fund up to $145 million to support BioNTech in broadening the scope of the manufacturing facility in Kigali, Rwanda. The partnership aims to develop local R&D, clinical, and commercial-scale manufacturing capacities for mRNA vaccines in Africa, ensuring equitable access and affordable pricing for low- and middle-income countries.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:15 pm

IKNA

Ikena Oncology shares are trading higher after the company announced it will discontinue development of IK-930 and evaluate strategic options for both the Company and its development pipeline.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:48 am

ASRT

Assertio has appointed Brendan P. O'Grady as the new Chief Executive Officer and a member of the Board, effective May 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:25 am

BITF

RIOT

Bitfarms has stated that Riot Platforms' offer significantly undervalues the company and its growth prospects. Bitfarms is currently undergoing a strategic alternatives process. The Special Committee requested confidentiality and non-solicitation protections from Riot, but Riot did not respond.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:13 am

BITF

RIOT

Bitfarms Ltd. has rejected a buyout offer from Riot Platforms, Inc., citing undervaluation. The Special Committee is reviewing strategic alternatives to maximize shareholder value, including potential business combinations or a sale. Bitfarms continues to focus on its growth and efficiency targets for 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:12 am

BLUE

bluebird bio has appointed James Sterling as its new CFO, effective June 10, 2024. Sterling will succeed Chris Krawtschuk. Sterling was previously the CFO of Renalytix plc.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:08 am

CTM

Castellum announced that Mark Fuller, Co-founder and CEO, will be stepping down. Glen Ives, currently the Chief Operating Officer, will take over as the new CEO effective July 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 10:49 am

LLAP

Terran Orbital has announced key appointments to its executive team to accelerate revenue growth and achieve free cash flow positivity.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 10:34 am

AAL

DAL

UAL

American Airlines (AAL) shares are trading lower after the company lowered its earnings and operating margin forecasts. This has also impacted shares of United Airlines (UAL) and Delta Air Lines (DAL). United Airlines reiterated its outlook, while American Airlines is undergoing a strategic shift and leadership changes.

Portfolio Pulse from Nabaparna Bhattacharya

May 29, 2024 | 10:27 am